What is the appropriate dose of isosorbide dinitrate (Isoket) infusion in acute coronary syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intravenous Nitroglycerin Dosing in ACS

For acute coronary syndrome, start intravenous nitroglycerin at 10 μg/min and titrate upward to achieve pain relief and hemodynamic tolerability, maintaining systolic blood pressure ≥90 mm Hg. 1

Initial Dosing Strategy

The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline provides explicit dosing for intravenous nitrates in ACS 1:

  • Starting dose: 10 μg/min IV infusion
  • Titration: Increase gradually based on:
    • Pain relief
    • Hemodynamic response
    • Blood pressure tolerance

Key Indications for IV Nitrates

Consider intravenous nitroglycerin (rather than sublingual) for 1:

  • Persistent anginal pain after sublingual nitrate therapy (up to 3 doses of 0.3-0.4 mg every 5 minutes)
  • ACS with hypertension
  • ACS with pulmonary edema

Critical Contraindications

Absolute contraindications - do not administer nitrates if 1:

  • Systolic blood pressure <90 mm Hg
  • Drop in SBP >30 mm Hg below baseline
  • Suspected right ventricular infarction (critical pitfall)
  • Recent phosphodiesterase-5 inhibitor use:
    • Within 12 hours of avanafil
    • Within 24 hours of sildenafil or vardenafil
    • Within 48 hours of tadalafil

Important Clinical Considerations

Tachyphylaxis develops after approximately 24 hours of continuous infusion 1. This is a common pitfall - the medication becomes less effective with prolonged use.

Hemodynamic monitoring requirements:

  • Maintain SBP ≥90 mm Hg throughout infusion
  • Use in hemodynamically stable patients only
  • Monitor for excessive hypotension during titration

Note on Isosorbide Dinitrate vs Nitroglycerin

While the question specifically asks about "Isoket" (isosorbide dinitrate), the current guideline evidence 1 specifically recommends nitroglycerin for IV infusion in ACS, not isosorbide dinitrate. The older research 2 from 1982 used isosorbide dinitrate at 3-7 mg/hour IV, but this is not reflected in current guideline recommendations. Follow the 2025 guideline recommendation for IV nitroglycerin starting at 10 μg/min rather than using isosorbide dinitrate infusion, as nitroglycerin is the standard of care with better-established dosing protocols for ACS.

Transition Strategy

When discontinuing IV nitrates after >24 hours, transition to oral isosorbide dinitrate (10 mg three times daily) prevents rebound vasoconstriction 3. Do not abruptly stop prolonged IV nitrate infusions without oral coverage.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.